Adamant Health
Developing and introducing world's first combined motion and EMG measurement and analysis service that's providing home measurements for people with movement disorders like Parkinson's disease.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
* | €2.2m | Seed | |
| Total Funding | 000k | ||
| EUR | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | (78 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (703 %) | - | (722 %) | (4806 %) |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Adamant Health is a pioneering startup that specializes in providing advanced measurement and analysis services for pharmaceutical companies and research organizations focused on movement disorders, such as Parkinson's disease. The company is based in Kuopio, Finland, and is a spinoff from the University of Eastern Finland, leveraging over 15 years of research in medical physics and artificial intelligence.
Adamant Health's core offering is its Measurement and Analysis Service, which combines neuromuscular function data (EMG) and motor symptom data collected through a small, wearable sensor. This technology allows for the collection of accurate, real-world data from patients in their home environments. The data is then analyzed to provide a detailed and continuous view of motor symptoms over a period of 24 to 48 hours or longer if needed.
The primary clients of Adamant Health are pharmaceutical companies and research organizations conducting clinical trials. By providing detailed and complete data coverage, Adamant Health enables these organizations to use smaller test groups, which can lead to faster and more cost-effective clinical trials. This is particularly beneficial for bringing new treatments to market more quickly and at a lower cost.
Adamant Health operates in the healthcare and biotechnology market, focusing on movement disorders. The company's business model revolves around offering its measurement and analysis services on a contractual basis to pharmaceutical companies and research organizations. Revenue is generated through service fees for data collection and analysis.
The team at Adamant Health includes experts with extensive experience in medical physics, clinical trials, and startup growth. This diverse expertise positions the company well to innovate and expand its services to clinical use with patients in the near future.
Keywords: Movement Disorders, EMG Data, Wearable Sensor, Clinical Trials, Pharmaceutical Companies, Research Organizations, Parkinson's Disease, Medical Physics, AI Analysis, Healthcare Innovation.